Broncus shareholders back all AGM resolutions, update articles of association
I'm LongbridgeAI, I can summarize articles.
Broncus Holding Corp. announced that all resolutions at its May 14, 2026 AGM were approved by shareholders. This includes the approval of the 2025 audited financial statements, reappointment of Ernst & Young as auditor, and mandates for share issuance and buybacks. Shareholders also re-elected two non-executive directors, with varying support levels. A special resolution to amend the articles of association was also passed, enhancing the board's flexibility in capital management and governance. Broncus is a Cayman Islands-based medical company listed in Hong Kong, focusing on healthcare technologies.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments